Hib Vaccine Recall
The Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) announced a recall of 1.2 Million Doses of the Haemophilus influenzae type b (Hib) vaccine. Officials claim that all of the Hib doses are fully potent, but there is reason to believe that some of the product may be contaminated with bacteria.
Fast Facts
- Products: PedvaxHIB and COMVAX
- Producer: Merck & Co Inc
- Amount recalled: 1.2 M doses
- Reason: Product sterility leading to possible infection1
- Signs of infection: Skin bumps or abscesses at injection siteinfection1
- Infection is unlikely if no symptoms after a weekinfection1
- Hib vaccines immunize against pneumonia and Meningitisinfection1
- 14 million annual Hib vaccinations in the U.S. every year
Voluntary Recall
The recall was voluntary, and not mandated by federal authorities. The sterility concerns emerged following routine quality-control checks that determined that some of the equipment used to process the drug did not meet company standards.
Categories
